{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:54:46Z","timestamp":1791312886750,"version":"4.3.1"},"reference-count":50,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,7,1]]},"abstract":"<jats:p>Objectives. Diminished bone density and a propensity to fracture with minimal trauma are common in children and adolescents with moderate to severe cerebral palsy (CP). The purpose of this study was to provide a detailed evaluation of bone mineral density (BMD) and metabolism in this population and to assess the relationship of these measures to multiple other clinical, growth, and nutrition variables.<\/jats:p>\n               <jats:p>Methods. The study group consisted of 117 subjects ages 2 to 19 years (mean: 9.7 years) with moderate to severe CP as defined by the Gross Motor Functional Classification scale. Population-based sampling was used to recruit 62 of the participants, which allows for estimations of prevalence. The remaining 55 subjects were a convenience sampling from both hospital- and school-based sources. The evaluation included measures of BMD, a detailed anthropometric assessment of growth and nutritional status, medical and surgical history, the Child Health Status Questionnaire, and multiple serum analyses. BMD was measured in the distal femur, a site specifically developed for use in this contracted population, and the lumbar spine. BMD measures were converted to age and gender normalized z scores based on our own previously published control series (n &amp;gt; 250).<\/jats:p>\n               <jats:p>Results. Osteopenia (BMD z score &amp;lt;\u22122.0) was found in the femur of 77% of the population-based cohort and in 97% of all study participants who were unable to stand and were older than 9 years. BMD was not as low in the lumbar spine (population-based cohort mean \u00b1 standard error z score: \u22121.8 \u00b1 0.1) as in the distal femur (mean z score: \u22123.1 \u00b1 0.2). Fractures had occurred in 26% of the children who were older than 10 years. Multiple clinical and nutritional variables correlated with BMD z scores, but interpretation of these findings is complicated by covariance among variables. In stepwise regression analyses, it was found that severity of neurologic impairment as graded by Gross Motor Functional Classification level, increasing difficulty feeding the child, use of anticonvulsants, and lower triceps skinfold z scores (in decreasing order of importance) all independently contribute to lower BMD z scores in the femur.<\/jats:p>\n               <jats:p>Conclusions. Low BMD is prevalent in children with moderate to severe CP and is associated with significant fracture risk. The underlying pathophysiology is complex, with multiple factors contributing to the problem and significant variation between different regions of the skeleton.<\/jats:p>","DOI":"10.1542\/peds.110.1.e5","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:17:55Z","timestamp":1092442675000},"page":"e5-e5","source":"Crossref","is-referenced-by-count":290,"title":["Bone Density and Metabolism in Children and Adolescents With Moderate to Severe Cerebral Palsy"],"prefix":"10.1542","volume":"110","author":[{"given":"Richard C.","family":"Henderson","sequence":"first","affiliation":[{"name":"Departments of Orthopaedics"},{"name":"Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Lark","sequence":"additional","affiliation":[{"name":"Departments of Orthopaedics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Gurka","sequence":"additional","affiliation":[{"name":"Biostatistics, University of North Carolina, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Worley","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen B.","family":"Fung","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Nutrition, Children\u2019s Hospital and Research Center at Oakland, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Conaway","sequence":"additional","affiliation":[{"name":"Departments of Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia A.","family":"Stallings","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Pediatrics, University of Virginia, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2002,7,1]]},"reference":[{"key":"2021121006210191000_R1","doi-asserted-by":"crossref","unstructured":"Henderson RC. Bone density and other possible predictors of fracture risk in children and adolescents with spastic quadriplegia. Dev Med Child Neurol.1997;39:224\u2013227","DOI":"10.1111\/j.1469-8749.1997.tb07415.x"},{"key":"2021121006210191000_R2","doi-asserted-by":"crossref","unstructured":"Lee JJK, Lyne ED. Pathologic fractures in severely handicapped children and young adults. J Pediatr Orthop.1990;10:497\u2013500","DOI":"10.1097\/01241398-199010040-00014"},{"key":"2021121006210191000_R3","doi-asserted-by":"crossref","unstructured":"McIvor WC, Samilson RL. Fractures in patients with cerebral palsy. J Bone Joint Surg Am.1966;48:858\u2013866","DOI":"10.2106\/00004623-196648050-00003"},{"key":"2021121006210191000_R4","unstructured":"Sturm PF, Alman BA, Christie BL. Femur fractures in institutionalized patients after hip spica immobilization. J Pediatr Orthop.1993;13:246\u2013248"},{"key":"2021121006210191000_R5","doi-asserted-by":"crossref","unstructured":"Pritchett JW. Treated and untreated unstable hips in severe cerebral palsy. Dev Med Child Neurol.1990;32:3\u20136","DOI":"10.1111\/j.1469-8749.1990.tb08460.x"},{"key":"2021121006210191000_R6","doi-asserted-by":"crossref","unstructured":"Sherk HH, Cruz M, Stambaugh J. Vitamin D prophylaxis and the lowered incidence of fractures in anticonvulsant rickets and osteomalacia. Clin Orthop.1977;129:251\u2013257","DOI":"10.1097\/00003086-197711000-00038"},{"key":"2021121006210191000_R7","doi-asserted-by":"crossref","unstructured":"Pritchett JW. The untreated unstable hip in severe cerebral palsy. Clin Orthop.1983;169\u2013172","DOI":"10.1097\/00003086-198303000-00022"},{"key":"2021121006210191000_R8","doi-asserted-by":"crossref","unstructured":"Tolman KG, Jubiz W, Sannella JJ, et al. Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children. Pediatrics.1975;56:45\u201351","DOI":"10.1542\/peds.56.1.45"},{"key":"2021121006210191000_R9","doi-asserted-by":"crossref","unstructured":"Stasikelis PJ, Lee DD, Sullivan CM. Complications of osteotomies in severe cerebral palsy. J Pediatr Orthop.1999;19:207\u2013210","DOI":"10.1097\/01241398-199903000-00014"},{"key":"2021121006210191000_R10","doi-asserted-by":"crossref","unstructured":"Henderson RC, Kemp GJ, Campion ER. Residual bone-mineral density and muscle strength after fractures of the tibia or femur in children. J Bone Joint Surg Am.1992;74:211\u2013218","DOI":"10.2106\/00004623-199274020-00007"},{"key":"2021121006210191000_R11","unstructured":"Thommessen M, Kase BF, Riis G, Heiberg A. The impact of feeding problems on growth and energy intake in children with cerebral palsy. Eur J Clin Health.1991;45:479\u2013487"},{"key":"2021121006210191000_R12","doi-asserted-by":"crossref","unstructured":"Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P. Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford feeding study. Dev Med Child Neurol.2000;42:674\u2013680","DOI":"10.1017\/S0012162200001249"},{"key":"2021121006210191000_R13","doi-asserted-by":"crossref","unstructured":"Stallings VA, Cronk CE, Zemel BS, Charney EB. Body composition in children with spastic quadriplegic cerebral palsy. J Pediatr.1995;126:833\u2013839","DOI":"10.1016\/S0022-3476(95)70424-8"},{"key":"2021121006210191000_R14","doi-asserted-by":"crossref","unstructured":"Henderson RC, Lin PP, Greene WB. Bone-mineral density in children and adolescents who have spastic cerebral palsy. J Bone Joint Surg Am.1995;77:1671\u20131681","DOI":"10.2106\/00004623-199511000-00005"},{"key":"2021121006210191000_R15","doi-asserted-by":"crossref","unstructured":"Hahn TJ. Bone complications of anticonvulsants. Drugs.1976;12:201\u2013211","DOI":"10.2165\/00003495-197612030-00003"},{"key":"2021121006210191000_R16","doi-asserted-by":"crossref","unstructured":"Crosley CJ, Chee C, Berman PH. Rickets associated with long-term anticonvulsant therapy in a pediatric outpatient population. Pediatrics.1975;56:52\u201357","DOI":"10.1542\/peds.56.1.52"},{"key":"2021121006210191000_R17","unstructured":"Greer FR, Tsang RC. Calcium and vitamin D metabolism in term and low birth weight infants. Perinatol Neonatol.1986;9:14\u201321"},{"key":"2021121006210191000_R18","doi-asserted-by":"crossref","unstructured":"Helin I, Landin LA, Nilsson BE. Bone mineral content in preterm infants at age 4 to 16. Acta Paediatr Scand.1985;74:264\u2013267","DOI":"10.1111\/j.1651-2227.1985.tb10962.x"},{"key":"2021121006210191000_R19","doi-asserted-by":"crossref","unstructured":"Henderson RC. Vitamin D levels in noninstitutionalized children with cerebral palsy. J Child Neurol.1997;12:443\u2013447","DOI":"10.1177\/088307389701200706"},{"key":"2021121006210191000_R20","doi-asserted-by":"crossref","unstructured":"Liptak GS, O\u2019Donnell M, Conaway M, et al. Health status of children with moderate to severe cerebral palsy. Dev Med Child Neurol.2001;43:364\u2013370","DOI":"10.1017\/S001216220100069X"},{"key":"2021121006210191000_R21","doi-asserted-by":"crossref","unstructured":"Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol.1997;39:214\u2013223","DOI":"10.1111\/j.1469-8749.1997.tb07414.x"},{"key":"2021121006210191000_R22","doi-asserted-by":"crossref","unstructured":"Landgraf JM, Abetz L, Ware JE. Child Health Questionnaire (CHQ): A User\u2019s Manual. Boston, MA: The Health Institute, New England Medical Center; 1996","DOI":"10.1037\/t05758-000"},{"key":"2021121006210191000_R23","doi-asserted-by":"crossref","unstructured":"Henderson RC, Lark RK, Newman JE, et al. Pediatric reference data for dual X-ray absorptiometric measures of normal bone density in the distal femur. AJR Am J Roentgenol.2002;178:439\u2013443","DOI":"10.2214\/ajr.178.2.1780439"},{"key":"2021121006210191000_R24","doi-asserted-by":"crossref","unstructured":"Harcke HT, Taylor A, Bachrach S, Miller F, Henderson RC. Lateral femoral scan: an alternative method for assessing bone mineral density in children with cerebral palsy. Pediatr Radiol.1998;28:241\u2013246","DOI":"10.1007\/s002470050341"},{"key":"2021121006210191000_R25","doi-asserted-by":"crossref","unstructured":"Henderson RC, Madsen CD. Bone density in children and adolescents with cystic fibrosis. J Pediatr.1996;128:28\u201334","DOI":"10.1016\/S0022-3476(96)70424-9"},{"key":"2021121006210191000_R26","doi-asserted-by":"crossref","unstructured":"Stevenson RD. Use of segmental measures to estimate stature in children with cerebral palsy. Arch Pediatr Adolesc Med.1995;149:658\u2013662","DOI":"10.1001\/archpedi.1995.02170190068012"},{"key":"2021121006210191000_R27","doi-asserted-by":"crossref","unstructured":"Chumlea WC, Guo SS, Steinbaugh ML. Prediction of stature from knee height for black and white adults and children with application to mobility-impaired or handicapped persons. J Am Diet Assoc.1994;94:1385\u20131388","DOI":"10.1016\/0002-8223(94)92540-2"},{"key":"2021121006210191000_R28","unstructured":"National Center for Health Statistics, Centers for Disease Control and Prevention. The Third National Health and Nutrition Examination Survey 1988\u20131994. Hyattsville, MD: National Center for Health Statistics; 1996"},{"key":"2021121006210191000_R29","doi-asserted-by":"crossref","unstructured":"Frisancho RA. Anthropometric Standards for the Assessment of Growth and Nutritional Status. Ann Arbor, MI: University of Michigan Press; 1990","DOI":"10.3998\/mpub.12198"},{"key":"2021121006210191000_R30","doi-asserted-by":"crossref","unstructured":"Sheth RD, Wesolowski CA, Jacob JC, et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr.1995;127:256\u2013262","DOI":"10.1016\/S0022-3476(95)70304-7"},{"key":"2021121006210191000_R31","doi-asserted-by":"crossref","unstructured":"Fung EB, Samson-Fang L, Stallings VA, et al. Feeding dysfunction is associated with poor growth and health status in children with cerebral palsy. J Am Diet Assoc.2002;102:361\u2013373","DOI":"10.1016\/S0002-8223(02)90084-2"},{"key":"2021121006210191000_R32","doi-asserted-by":"crossref","unstructured":"Musgrave KO, Giambalvo L, Leclerc HL, Cook RA, Rosen CJ. Validation of a quantitative food frequency questionnaire for rapid assessment of dietary calcium intake. J Am Diet Assoc.1989;89:1484\u20131488","DOI":"10.1016\/S0002-8223(21)02399-3"},{"key":"2021121006210191000_R33","doi-asserted-by":"crossref","unstructured":"Pedrazzoni M, Alfano FS, Girasole G, et al. Clinical observations with a new specific assay for bone alkaline phosphatase: a cross-sectional study in osteoporotic and Pagetic subjects and a longitudinal evaluation of the response to ovariectomy, estrogens, and bisphosphonates. Calcif Tissue Int.1996;59:334\u2013338","DOI":"10.1007\/s002239900136"},{"key":"2021121006210191000_R34","doi-asserted-by":"crossref","unstructured":"Johansen JS, Giwercman A, Hartwell D, et al. Serum bone gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, serum testosterone. J Clin Endrocrinol Metab.1988;67:273\u2013278","DOI":"10.1210\/jcem-67-2-273"},{"key":"2021121006210191000_R35","doi-asserted-by":"crossref","unstructured":"Gertz BJ, Clemens JD, Holland SD, Yuan W, Greenspan S. Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment. Calcif Tissue Int.1998;63:102\u2013106","DOI":"10.1007\/s002239900497"},{"key":"2021121006210191000_R36","doi-asserted-by":"crossref","unstructured":"Jekovec-Vrhovsek M, Kocijancic A, Prezelj J. Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care. Dev Med Child Neurol.2000;42:403\u2013405","DOI":"10.1017\/S0012162200000736"},{"key":"2021121006210191000_R37","doi-asserted-by":"crossref","unstructured":"Wilmshurst S, Ward K, Adams JE, Langton CM, Mughal MZ. Mobility status and bone density in cerebral palsy. Arch Dis Child.1996;75:164\u2013165","DOI":"10.1136\/adc.75.2.164"},{"key":"2021121006210191000_R38","doi-asserted-by":"crossref","unstructured":"Chad KE, Bailey DA, McKay HA, Zello GA, Snyder RE. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr.1999;135:115\u2013117","DOI":"10.1016\/S0022-3476(99)70340-9"},{"key":"2021121006210191000_R39","doi-asserted-by":"crossref","unstructured":"Shaw NJ, White CP, Fraser WD, Rosenbloom L. Osteopenia in cerebral palsy. Arch Dis Child.1994;71:235\u2013238","DOI":"10.1136\/adc.71.3.235"},{"key":"2021121006210191000_R40","doi-asserted-by":"crossref","unstructured":"Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res.1992;7:137\u2013145","DOI":"10.1002\/jbmr.5650070204"},{"key":"2021121006210191000_R41","doi-asserted-by":"crossref","unstructured":"Cowell CT, Lu PW, Lloyd-Jones SA, et al. Volumetric bone mineral density: a potential role in paediatrics. Acta Paediatr Suppl.1995;411:12\u201316","DOI":"10.1111\/j.1651-2227.1995.tb13852.x"},{"key":"2021121006210191000_R42","doi-asserted-by":"crossref","unstructured":"Stevenson RD, Hayes RP, Blackman JA. Clinical correlates of linear growth in children with cerebral palsy. Dev Med Child Neurol.1994;36:135\u2013142","DOI":"10.1111\/j.1469-8749.1994.tb11822.x"},{"key":"2021121006210191000_R43","doi-asserted-by":"crossref","unstructured":"Krick J, Murphy-Miller P, Zeger S, Wright E. Pattern of growth in children with cerebral palsy. J Am Diet Assoc.1996;96:680\u2013685","DOI":"10.1016\/S0002-8223(96)00188-5"},{"key":"2021121006210191000_R44","doi-asserted-by":"crossref","unstructured":"Stevenson RD, Roberts CD, Vogtle L. The effects of non-nutritional factors on growth in cerebral palsy. Dev Med Child Neurol.1995;37:124\u2013130","DOI":"10.1111\/j.1469-8749.1995.tb11981.x"},{"key":"2021121006210191000_R45","doi-asserted-by":"crossref","unstructured":"Shapiro BK, Green P, Krick J, Allen D, Capute AJ. Growth of severely impaired children: neurological versus nutritional factors. Dev Med Child Neurol.1986;28:729\u2013733","DOI":"10.1111\/j.1469-8749.1986.tb03924.x"},{"key":"2021121006210191000_R46","doi-asserted-by":"crossref","unstructured":"Stallings VA, Charney EB, Davies JC, Cronk CE. Nutrition-related growth failure of children with quadriplegic cerebral palsy. Dev Med Child Neurol.1993;35:126\u2013138","DOI":"10.1111\/j.1469-8749.1993.tb11614.x"},{"key":"2021121006210191000_R47","doi-asserted-by":"crossref","unstructured":"Larson CM, Henderson RC. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop.2000;20:71\u201374","DOI":"10.1097\/01241398-200001000-00016"},{"key":"2021121006210191000_R48","doi-asserted-by":"crossref","unstructured":"Sanders KD, Cox K, Cannon R, et al. Growth response to enteral feeding by children with cerebral palsy. JPEN J Parenter Enteral Nutr.1990;14:23\u201326","DOI":"10.1177\/014860719001400123"},{"key":"2021121006210191000_R49","doi-asserted-by":"crossref","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med.1998;339:947\u2013952","DOI":"10.1056\/NEJM199810013391402"},{"key":"2021121006210191000_R50","unstructured":"Henderson RC, Lark RK, Kecskemethy HH, Miller F, Harcke HT, Bachrach SJ. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. J Pediatr. In press"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/110\/1\/e5\/1115773\/pe07020000e5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/110\/1\/e5\/1115773\/pe07020000e5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T14:23:21Z","timestamp":1639146201000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/110\/1\/e5\/64097\/Bone-Density-and-Metabolism-in-Children-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,7,1]]},"published-print":{"date-parts":[[2002,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.110.1.e5","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}